Legend Biotech (LEGN) Appoints Peter Salovey to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors
August 8, 2024 4:05 PM EDTSOMERSET, N.J., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, today announced the appointment of Peter Salovey, Ph.D., President Emeritus of Yale University, to its Board of Directors. Dr. Salovey will serve as an independent director, effective August 9.
We are pleased to welcome Dr. Salovey to the Legend Board, said Ying Huang, Ph.D., Chief Executive Officer of Legend Biotech. Dr. Saloveys deep experience and wealth of knowledge in medical research and public health will be invaluable to... More
